Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world’s population. For decades, the heterogeneity of non-alcoholic fatty liver disease (NAFLD) has impeded our understanding of the disease mechanism...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao, Mingfeng Xia
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-04-01
Col·lecció:	Lipids in Health and Disease
Matèries:	Metabolic dysfunction-associated fatty liver disease Hepatic lipid metabolism Multisystem disease Pathophysiology Medications Clinical trials
Accés en línia:	https://doi.org/10.1186/s12944-024-02092-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!